Structural alterations of transforming growth factor-β receptor genes in human cervical carcinoma

International Journal of Cancer

Volumn 82, Issue 1, 1999, Pages 43-51

  Chen, Taiping ^a   De Vries, E G E ^b   Hollema, H ^b   Yegen, H A ^a   Vellucci, V F ^a   Strickler, H D ^c   Hildesheim, A ^c   Reiss, M ^a,d  

^a YALE CANCER CENTER   (United States)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c NATIONAL CANCER INSTITUTE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ALLELE; AMINO TERMINAL SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; FEMALE; GENE MUTATION; GENE SEQUENCE; GENE STRUCTURE; HUMAN; HUMAN TISSUE; INTRON; PRIORITY JOURNAL; RNA SPLICING; SIGNAL TRANSDUCTION; UTERINE CERVIX CARCINOMA;

ADULT; AGED; AMINO ACID SEQUENCE; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRINUCLEOTIDE REPEATS; UTERINE CERVICAL NEOPLASMS;

EID: 0033516627     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990702)82:1<43::AID-IJC9>3.0.CO;2-0     Document Type: Article

References (25)

1. BRAUN, L., DURST, M., MIKUMO, R. and GRUPPUSO, P., Differential response of non-tumorigenic and tumorigenic human papillomavirus type 16-positive epithelial cells to transforming growth factor β1. Cancer Res., 50, 7324-7332 (1990).
2. CANHOTO, A.J., PIRISI, L. and CREEK, K.E., The 5-prime segment of the human papillomavirus type 16 (HPV16) enhancer is required for transforming growth factor-beta (TGF-β) inhibition of HPV early gene expression. Proc. Amer. Assoc. Cancer Res., 38, 160 (1997).
3. CHEN, T., CARTER, D., GARRIGUE-ANTAR, L. and REISS, M., Transforming growth factor-β type I receptor kinase mutant associated with metastatic breast cancer. Cancer Res., 58, 4805-4810 (1998).
4. COMERCI, J.T., JR., RUNOWICZ, C.D., FLANDERS, K.C., DE VICTORIA, C., FIELDS, A.L., KADISH, A.S. and GOLDBERO, G.L., Altered expression of transforming growth factor-beta 1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix. Cancer, 77, 1107-1114 (1996).
5. COOPER, T.A. and MATTOX, W., The regulation of splice-site selection, and its role in human disease. Amer. J. Hum. Genet., 61, 259-266 (1997).
6. CREEK, K.E., GESLANI, G., BATOVA, A. and PIRISI, L., Progressive loss of sensitivity to growth control by retinoic acid and transforming growth factor-beta at late stages of human papillomavirus type 16-initiated transformation of human keratinocytes. Adv. exp. Med. Biol., 375, 117-135 (1995).
7. DE GEEST, K., BERGMAN, C.A., TURYK, M.E., FRANK, B.S. and WILBANKS, G.D., Differential response of cervical intraepithelial and cervical carcinoma cell lines to transforming growth factor-β1. Gynecol. Oncol., 55, 376-385 (1994).
8. DECOTEAU, J.F., KNAUS, P.I., YANKELEV, H., REIS, M.D., LOWSKY, R., LODISH, H.F. and KADIN, M.E., Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia. Proc. nat. Acad. Sci. (Wash.), 94, 5877-81 (1997).
9. FRANZÉN, P., TEN DUKE, P., ICHIJO, H., YAMASHITA, H., SCHULZ, P., HELDIN, C.-H. and MIYAZONO, K., Cloning of a TGFβ type I receptor that forms a heterodimeric complex with the TGFβ type II receptor. Cell, 75, 681-692 (1993).
10. HELDIN, C.-H., MIYAZONO, K. and TEN DUKE, P., TGFβ signaling from cell membrane to nucleus through SMAD proteins. Nature (Lond.), 390, 465-471 (1997).
11. HOWLEY, P.M., Role of the human papillomaviruses in human cancer. Cancer Res., 51, 5019s-5022s (1991).
12. KANG S.H., WON, K., CHUNG, H.W., JONG, H.S., SONG, Y.S., KIM, S.J., BANG, Y.J. and KIM, N.K., Genetic integrity of transforming growth factor beta (TGF-beta) receptors in cervical carcinoma cell lines: loss of growth sensitivity but conserved transcriptional response to TGF-beta. Int. J. Cancer, 77, 620-625 (1998).
13. KIM, C.H., OH, Y. and LEE, T.H., Codon optimization for high-level expression of human erythropoietin (EPO) in mammalian cells. Gene, 199, 293-301 (1997).
14. KIM, J.W., KIM, H.S., KIM, I.K., KIM, M.R., CHO, E.Y., KIM, H.K., LEE, J.M. and NAMKOONG, S.E., Transforming growth factor-beta 1 induces apoptosis through down-regulation of c-myc gene and overexpression of p27Kip1 protein in cervical carcinoma. Gynecol. Oncol., 69, 230-236 (1998).
15. Koss, L.G., STEWART, F.W., FOOTE, F.W., JORDAN, M.J., BADER, G.M. and DAY, E., Some histological aspects of behavior of epidermoid carcinoma in situ and related lesions of the uterine cervix. Cancer, 16, 1160-1211 (1963).
16. LAGNEAUX, L., DELFORGE, A., BRON, D., MASSY, M., BERNIER, M. and STRYCKMANS, P., Heterogenous response of B lymphocytes to transforming growth factor-beta in B-cell chronic lymphocytic leukaemia: correlation with the expression of TGF-beta receptors. Br. J. Haematol., 97, 612-620 (1997).
17. LIN, H.Y., MOUSTAKAS, A., KNAUS, P., WELLS, R.G., HENIS, Y.I. and LODISCH, H.F., The soluble exoplasmic domain of the type II transforming growth factor (TGFβ) receptor. J. biol. Chem., 270, 2747-2754 (1995).
18. LU, S.L., ZHANG, W.C., AKIYAMA, Y., NOMIZU, T. and YUASA, Y., Genomic structure of the transforming growth factor beta type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers. Cancer Res., 56, 4595-4598 (1996).
19. MARKOWITZ, S. and 12 OTHERS, Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability [see comments]. Science, 268, 1336-1338 (1995).
20. PARKER, S.L., DAVIS, K.J., WINGO, P.A., RIES, L.A. and HEATH, C.W., Jr., Cancer statistics by race and ethnicity. CA Cancer J. Clin., 48, 31-48 (1998).
21. PASCHE, B., Luo, Y., RAO, P.H., NIMER, S.D., DMITROVSKY, E., CARON, P., LUZZATTO, L., OFFIT, K., CORDON-CARDO, C., RENAULT, B., SATAGOPAN, J.M., MURTY, V.V. and MASSAGUÉ, J., Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract. Cancer Res., 58, 2727-2732 (1998).
22. RAMP, U., JAQUET, K., REINECKE, P., NITSCH, T., GABBERT, H.E. and GERHARZ, C.D., Acquisition of TGF-beta 1 resistance: an important progression factor in human renal cell carcinoma. Lab. Invest., 76, 739-49 (1997).
23. REISS, M., Transforming growth factor-beta and cancer: a love-hate relationship? Oncol. Res., 9, 447-57 (1997).
24. WOODWORTH, C.D., NOTARIO, V. and DIPAOLO, J.A., Transforming Growth Factors beta 1 and 2 transcriptionally regulate human papillomavirus (HPV) type 16 early gene expression in HPV-immortalized human genital epithelial cells. J. Virol., 64, 4767-4775 (1990).
25. ZAWEL, L., DAI, J.L., BUCKHAULTS, P., ZHOU, S., KINZLER, K.W., VOGELSTEIN, B. and KERN, S.E., Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell, 1, 611-617 (1998).